"Ocular Hypertension" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
| Descriptor ID |
D009798
|
| MeSH Number(s) |
C11.525
|
| Concept/Terms |
Ocular Hypertension- Ocular Hypertension
- Hypertension, Ocular
- Hypertensions, Ocular
- Ocular Hypertensions
Glaucoma, Suspect- Glaucoma, Suspect
- Glaucomas, Suspect
- Suspect Glaucoma
- Suspect Glaucomas
|
Below are MeSH descriptors whose meaning is more general than "Ocular Hypertension".
Below are MeSH descriptors whose meaning is more specific than "Ocular Hypertension".
This graph shows the total number of publications written about "Ocular Hypertension" by people in this website by year, and whether "Ocular Hypertension" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2019 | 1 | 2 | 3 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ocular Hypertension" by people in Profiles.
-
Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia. Exp Eye Res. 2022 11; 224:109250.
-
Evidence for ceramide induced cytotoxicity in retinal ganglion cells. Exp Eye Res. 2021 10; 211:108762.
-
The Impact of OCT on Diagnostic Accuracy of the Technology-Based Eye Care Services Protocol: Part II of the Technology-Based Eye Care Services Compare Trial. Ophthalmology. 2020 04; 127(4):544-549.
-
Diagnostic Accuracy of Technology-based Eye Care Services: The Technology-based Eye Care Services Compare Trial Part I. Ophthalmology. 2020 01; 127(1):38-44.
-
Treatment of canine postoperative ocular hypertension with combined latanoprost 0.005% and atropine 1% ophthalmic solutions. Vet Ophthalmol. 2019 Jul; 22(4):448-461.
-
Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension. Invest Ophthalmol Vis Sci. 2014 Oct 30; 55(11):7486-93.
-
FR-190997, a nonpeptide bradykinin B2-receptor partial agonist, is a potent and efficacious intraocular pressure lowering agent in ocular hypertensive cynomolgus monkeys. Drug Dev Res. 2014 Jun; 75(4):211-23.
-
Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model. Invest Ophthalmol Vis Sci. 2013 Mar 11; 54(3):1816-28.
-
Intraocular pressure elevation during early postoperative period after secondary intraocular lens implantation in children and adolescents. J Cataract Refract Surg. 2012 Sep; 38(9):1633-6.
-
Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model. Invest Ophthalmol Vis Sci. 2012 Jun 28; 53(7):4289-98.